MIF inhibitors (AVANIR)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameMIF inhibitors (AVANIR)
Drug Alias Namemacrophage migration inhiitor (Novartis)macrophage migration inhibitors (Ciblex)macrophage migration inhibitor (AVANIR)AVP-26463AVP-13748 +[7] 
ClassificationSmall molecules
Mechanisms of ActionMacrophage migration inhibitory factor inhibitors
TargetsMacrophage migration inhibitory factor
Therapy Area/IndicationsInflammationAutoimmune DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCiblex
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis AgCiblexAvanir Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A